Respiratory infections reduced by 63 percent with 4000 IU vitamin D daily - RCT Dec 2012

Highlights of Report in Swedish translated by Google

  • Peter Bergman and his colleagues are fortunate to have 140 patients in daily treatment for one year with either vitamin D (4000 IU) or a placebo.
  • The study was double-blind: neither the patients - all of which were susceptible to infections - nor caregivers knew who belonged to which group before the trial was over.
  • The results show that vitamin D reduced patient discomfort.
  • The probability of requiring treatment with antibiotics during the study period was 63 % lower in the vitamin D group compared with the placebo group, and the incidence of fungal infections, including respiratory, decreased.

Chart from 2015 publication
Image
Note: if takes ~100 days for the vitamin D levels to plateau (thus, no benefit is expected until then)
Respiratory tract infection eliminated in 36 percent of people

Types of Respiratory Infections

Image

Vitamin D did particularly well with

  • Moraxella catharralis
  • Staphylococcus aureus
  • Pseudomona aeruginosa
  • Fungal infection

Adverse effects: fewer with vitamin D than with placebo

Image

Suspect that Vitamin D caused the reduction in:

  • Gastrointestinal
  • Cardiovascular
  • Infections

The RTI aspects

Image

 Download the English 2012 PDF from VitaminDWiki


 Download the English 2015 PDF from VitaminDWiki


See also VitaminDWiki

Image

See also web

319041 visitors, last modified 27 Jan, 2024,
Printer Friendly Follow this page for updates